Philip D'Arcy Hart

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Hart in 1973

Philip Montagu D’Arcy Hart, CBE, (25 June 1900 – 30 July 2006) was a seminal British medical researcher and pioneer in tuberculosis treatment.

Personal life[edit]

Philip D'Arcy Hart was the grandson of Samuel Montagu, 1st Baron Swaythling.

In 1941, he married Ruth Meyer, later a medical gynaecologist. They had a son, the economist Oliver Hart.

Philip D'Arcy Hart died at the age of 106 in 2006.[1]

Career[edit]

Hart became a consultant physician at University College Hospital at the age of 34. Three years later, he joined the Medical Research Council (MRC).

Hart became involved with much of the MRC's early research into dust diseases in coal miners. He was a member of the MRC Streptomycin in Tuberculosis Trials Committee; their study evaluating the use of streptomycin in treating tuberculosis is generally accepted as the first randomized clinical trial. At the age of 71, Hart published a seminal paper in the Journal of Experimental Medicine, showing that the intracellular pathogen Mycobacterium tuberculosis avoids destruction in the cell's lysosomes by circumventing these organelles altogether—a trick now known to be used by many other intracellular pathogens.

References[edit]

External links[edit]

  • Tansey, Tilli. Obituary, James Lind Library.
  • Draper, Philip; Skehel, John. Obituary, The Guardian, 30 August 2006.